CAS: 620113-73-7 - (2E)-2-(1,3-benzothiazol-2-yl)-3-[2-(4-fluorophenoxy)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]prop-2-enenitrile
Formula:C25H15FN4O2S
InChI:InChI=1/C25H15FN4O2S/c1-15-5-4-12-30-22(15)29-23(32-18-10-8-17(26)9-11-18)19(25(30)31)13-16(14-27)24-28-20-6-2-3-7-21(20)33-24/h2-13H,1H3/b16-13+
- Synonyms:
- (2E)-2-(1,3-Benzothiazol-2-yl)-3-[2-(4-fluorophenoxy)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]acrylonitrile
- 2-benzothiazoleacetonitrile, alpha-[[2-(4-fluorophenoxy)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]methylene]-, (alphaE)-
alpha-[[2-(4-Fluorophenoxy)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl]methylene]-2-benzothiazoleacetonitrile
CAS:620113-73-7
Formula:
C25H15FN4O2S
Molecular weight:
454.4756
Ref: AN-AG00ECD8
Undefined size | To inquire |
Estimated delivery in United States, on Friday 10 May 2024
CCG-63808
CAS:620113-73-7
CCG-63808 is a reversible inhibitor of regulator of G-protein signaling (RGS) proteins. CCG-63808 dose-dependently inhibits …
Formula:
C25H15FN4O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
454.48
Ref: TM-T14898
1mg | 51.00 € | |
2mg | 67.00 € | |
5mg | 94.00 € | |
10mg | 137.00 € | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Friday 17 May 2024
CCG 63808
CAS:620113-73-7
Reversible inhibitor of RGS proteins
Formula:
C25H15FN4O2S
Purity:
Min. 95%
Molecular weight:
454.08998
Ref: 3D-FC64972
10mg | 140.00 € | |
50mg | 372.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024